Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 27, 2002. The report details a specific corporate action regarding share re-purchases authorized by shareholders at the Annual General Meeting on May 20, 2002.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share re-purchase transaction:
- Shares Purchased: 800,000 ordinary shares
- Price Per Share: 1,247.1916p
- Transaction Purpose: Purchase for cancellation
Material Changes
The filing does not report material changes in operating results or financial position compared to prior periods. The primary event is the reduction of the company's share capital through the cancellation of 800,000 shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, outlook, risk factors, or contingencies. It is a procedural announcement of a completed share buyback.
Investor Verification Points
- Verify the total number of shares remaining outstanding following the cancellation of 800,000 shares.
- Confirm the total cash outflow for this specific transaction (800,000 shares multiplied by 1,247.1916p).
- Check subsequent filings for the remaining authority available for share re-purchases under the May 20, 2002 shareholder mandate.